Record Information |
---|
Version | 1.0 |
---|
Created at | 2022-09-09 22:18:57 UTC |
---|
Updated at | 2022-09-09 22:18:57 UTC |
---|
NP-MRD ID | NP0291285 |
---|
Secondary Accession Numbers | None |
---|
Natural Product Identification |
---|
Common Name | (1r,2r,3z,8s,9s,10r,11s,12s,13r,15s,18s,19s)-18-(furan-3-yl)-8,10-dihydroxy-2,8,12,19-tetramethyl-5,16-dioxo-6,14,17-trioxapentacyclo[10.9.0.0²,⁹.0¹³,¹⁵.0¹³,¹⁹]henicos-3-en-11-yl 2-[(2-hydroxy-3-methylbutanoyl)oxy]-3-methylbutanoate |
---|
Description | DYSOXYLUMOLIDE C belongs to the class of organic compounds known as depsipeptides. These are natural or synthetic compounds having sequences of amino and hydroxy carboxylic acid residues (usually α-amino and α-hydroxy acids), commonly but not necessarily regularly alternating. It was first documented in 2022 (PMID: 36115679). Based on a literature review a significant number of articles have been published on DYSOXYLUMOLIDE C (PMID: 36115650) (PMID: 36115671) (PMID: 36115642) (PMID: 36115638) (PMID: 36115559) (PMID: 36115606). |
---|
Structure | CC(C)C(O)C(=O)OC(C(C)C)C(=O)O[C@@H]1[C@H](O)[C@@H]2[C@](C)(\C=C/C(=O)OC[C@@]2(C)O)[C@H]2CC[C@@]3(C)[C@@H](OC(=O)[C@H]4O[C@@]34[C@]12C)C1=COC=C1 InChI=1S/C36H48O13/c1-17(2)22(38)29(40)46-24(18(3)4)30(41)48-27-23(39)25-32(5,12-10-21(37)45-16-34(25,7)43)20-9-13-33(6)26(19-11-14-44-15-19)47-31(42)28-36(33,49-28)35(20,27)8/h10-12,14-15,17-18,20,22-28,38-39,43H,9,13,16H2,1-8H3/b12-10-/t20-,22?,23-,24?,25-,26+,27-,28-,32-,33+,34-,35+,36-/m1/s1 |
---|
Synonyms | Not Available |
---|
Chemical Formula | C36H48O13 |
---|
Average Mass | 688.7670 Da |
---|
Monoisotopic Mass | 688.30949 Da |
---|
IUPAC Name | (1R,2R,3Z,8S,9S,10R,11S,12S,13R,15S,18R,19S)-18-(furan-3-yl)-8,10-dihydroxy-2,8,12,19-tetramethyl-5,16-dioxo-6,14,17-trioxapentacyclo[10.9.0.0^{2,9}.0^{13,15}.0^{13,19}]henicos-3-en-11-yl 2-[(2-hydroxy-3-methylbutanoyl)oxy]-3-methylbutanoate |
---|
Traditional Name | (1R,2R,3Z,8S,9S,10R,11S,12S,13R,15S,18R,19S)-18-(furan-3-yl)-8,10-dihydroxy-2,8,12,19-tetramethyl-5,16-dioxo-6,14,17-trioxapentacyclo[10.9.0.0^{2,9}.0^{13,15}.0^{13,19}]henicos-3-en-11-yl 2-[(2-hydroxy-3-methylbutanoyl)oxy]-3-methylbutanoate |
---|
CAS Registry Number | Not Available |
---|
SMILES | CC(C)C(O)C(=O)OC(C(C)C)C(=O)O[C@@H]1[C@H](O)[C@@H]2[C@](C)(\C=C/C(=O)OC[C@@]2(C)O)[C@H]2CC[C@@]3(C)[C@@H](OC(=O)[C@H]4O[C@@]34[C@]12C)C1=COC=C1 |
---|
InChI Identifier | InChI=1S/C36H48O13/c1-17(2)22(38)29(40)46-24(18(3)4)30(41)48-27-23(39)25-32(5,12-10-21(37)45-16-34(25,7)43)20-9-13-33(6)26(19-11-14-44-15-19)47-31(42)28-36(33,49-28)35(20,27)8/h10-12,14-15,17-18,20,22-28,38-39,43H,9,13,16H2,1-8H3/b12-10-/t20-,22?,23-,24?,25-,26+,27-,28-,32-,33+,34-,35+,36-/m1/s1 |
---|
InChI Key | RCYZADKTJDQLRC-DPEZKNQOSA-N |
---|
Experimental Spectra |
---|
|
| Not Available | Predicted Spectra |
---|
|
| Spectrum Type | Description | Depositor ID | Depositor Organization | Depositor | Deposition Date | View |
---|
1D NMR | 13C NMR Spectrum (1D, 25 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 100 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 252 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 1000 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 50 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 200 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 75 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 300 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 101 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 400 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 126 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 500 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 151 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 600 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 176 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 700 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 201 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 800 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 226 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 900 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum |
| Chemical Shift Submissions |
---|
|
| Not Available | Species |
---|
Species of Origin | Not Available |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as depsipeptides. These are natural or synthetic compounds having sequences of amino and hydroxy carboxylic acid residues (usually α-amino and α-hydroxy acids), commonly but not necessarily regularly alternating. |
---|
Kingdom | Organic compounds |
---|
Super Class | Organic acids and derivatives |
---|
Class | Peptidomimetics |
---|
Sub Class | Depsipeptides |
---|
Direct Parent | Depsipeptides |
---|
Alternative Parents | |
---|
Substituents | - Depsipeptide
- Naphthopyran
- Tetracarboxylic acid or derivatives
- Naphthalene
- Delta_valerolactone
- Fatty acid ester
- Dioxepane
- Delta valerolactone
- 1,4-dioxepane
- Fatty acyl
- Pyran
- Oxane
- Heteroaromatic compound
- Alpha,beta-unsaturated carboxylic ester
- Enoate ester
- Tertiary alcohol
- Furan
- Cyclic alcohol
- Secondary alcohol
- Lactone
- Carboxylic acid ester
- Oxacycle
- Organoheterocyclic compound
- Ether
- Oxirane
- Dialkyl ether
- Carboxylic acid derivative
- Organic oxygen compound
- Organic oxide
- Hydrocarbon derivative
- Organooxygen compound
- Carbonyl group
- Alcohol
- Aromatic heteropolycyclic compound
|
---|
Molecular Framework | Aromatic heteropolycyclic compounds |
---|
External Descriptors | Not Available |
---|
Physical Properties |
---|
State | Not Available |
---|
Experimental Properties | Property | Value | Reference |
---|
Melting Point | Not Available | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | Not Available | Not Available | LogP | Not Available | Not Available |
|
---|
Predicted Properties | |
---|
General References | - Sharma S, Zaher S, Rodrigues PRS, Davies LC, Edkins S, Strang A, Chakraborty M, Watkins WJ, Andrews R, Parkinson E, Angelopoulos N, Moet L, Shepherd F, Davies KMM, White D, Oram S, Siddall K, Keeping V, Simpson K, Faggian F, Bray M, Bertorelli C, Bell S, Collis RE, McLaren JE, Labeta M, O'Donnell VB, Ghazal P: mSep: investigating physiological and immune-metabolic biomarkers in septic and healthy pregnant women to predict feto-maternal immune health - a prospective observational cohort study protocol. BMJ Open. 2022 Sep 17;12(9):e066382. doi: 10.1136/bmjopen-2022-066382. [PubMed:36115679 ]
- Monckton CP, Brougham-Cook A, Underhill GH, Khetani SR: Modulation of human iPSC-derived hepatocyte phenotype via extracellular matrix microarrays. Acta Biomater. 2022 Sep 14. pii: S1742-7061(22)00577-3. doi: 10.1016/j.actbio.2022.09.013. [PubMed:36115650 ]
- Wang Y, Xiang Y, Liao O, Wu Y, Li Y, Du Q, Ye J: Short-term outcomes and intermediate-term follow-up of Helicobacter pylori infection treatment for naive patients: a retrospective observational study. BMJ Open. 2022 Sep 17;12(9):e062096. doi: 10.1136/bmjopen-2022-062096. [PubMed:36115671 ]
- Li S, Zhao R, Yang Q, Wu M, Ma J, Wei Y, Pang Z, Wu C, Liu Y, Gu Y, Liao M, Sun H: Phylogenetic and pathogenic characterization of current fowl adenoviruses in China. Infect Genet Evol. 2022 Sep 14;105:105366. doi: 10.1016/j.meegid.2022.105366. [PubMed:36115642 ]
- Applebaum AJ, Loschiavo M, Morgan K, Mennin DS, Fresco DM, Hoyt MA, Schofield E, O'Toole MS, Cohn J, Jacobs JM: A randomized controlled trial of emotion regulation therapy for cancer caregivers: A mechanism-targeted approach to addressing caregiver distress. Contemp Clin Trials. 2022 Sep 14;122:106923. doi: 10.1016/j.cct.2022.106923. [PubMed:36115638 ]
- Brenes-Alvarado A, Soto-Montero J, Farias-da-Silva FF, Benine-Warlet J, Ribeiro AF, Groppo FC, Steiner-Oliveira C: Does potassium iodide help in the microbial reduction of oral microcosm biofilms after photodynamic therapy with methylene blue and red laser? Photodiagnosis Photodyn Ther. 2022 Dec;40:103123. doi: 10.1016/j.pdpdt.2022.103123. Epub 2022 Sep 14. [PubMed:36115559 ]
- Loor A, Wang D, Bossier P, Nevejan N: beta-1,3-Glucan/chitin unmasking in the Saccharomyces cerevisiae mutant, Deltamnn9, promotes immune response and resistance of the Pacific oyster (Crassostrea gigas) to Vibrio coralliilyticus infection. Fish Shellfish Immunol. 2022 Dec;131:470-479. doi: 10.1016/j.fsi.2022.09.019. Epub 2022 Sep 15. [PubMed:36115606 ]
- Sena C, Ohene-Adjei M, Deng S, Patibandla N, May B, de Ferranti SD, Starc TJ, Thaker VV: Lack of Age-Appropriate Reference Intervals Causing Potentially Missed Alerts in Clinical Reports of Dyslipidemia. J Pediatr. 2023 Jan;252:208-212.e3. doi: 10.1016/j.jpeds.2022.08.017. Epub 2022 Sep 15. [PubMed:36115623 ]
- Osterlund N, Vosselman T, Leppert A, Graslund A, Jornvall H, Ilag LL, Marklund EG, Elofsson A, Johansson J, Sahin C, Landreh M: Mass Spectrometry and Machine Learning Reveal Determinants of Client Recognition by Antiamyloid Chaperones. Mol Cell Proteomics. 2022 Oct;21(10):100413. doi: 10.1016/j.mcpro.2022.100413. Epub 2022 Sep 15. [PubMed:36115577 ]
- Pham LP, Nguyen MV, Jordal AO, Ronnestad I: Metabolic rates, feed intake, appetite control, and gut transit of clownfish Amphiprion ocellaris exposed to increased temperature and limited feed availability. Comp Biochem Physiol A Mol Integr Physiol. 2022 Dec;274:111318. doi: 10.1016/j.cbpa.2022.111318. Epub 2022 Sep 14. [PubMed:36115553 ]
- LOTUS database [Link]
|
---|